… with potentially interacting drugs (such as amiodarone, 25 … ) were not contraindications to
perhexiline therapy at entry. … details regarding concomitant CYP2D6 inhibitor therapy, this study …

… • Current treatment with perhexiline or previous adverse reaction to perhexiline at therapeutic
… of recurrent hypoglycemia• Concomitant use of amiodarone, ranolazine or trimetazidine• …

… case report, the histopathology showed an absence of steatosis and phospholipidosis,
despite years of amiodarone … , such as amiodarone and perhexiline, drugs that can accelerate …

… uptake of both perhexiline enantiomers in patients were slow… against the background of
concomitant therapy with other insulin-… compound, structurally similar to amiodarone) was also …

… for such therapies (for example because of concomitant severe systolic heart failure) and
by the … of the anti-ischaemic effects of perhexiline and amiodarone. However, excessive or …

… to monitor patients receiving concomitant dabigatran and … , and C alleles were more common
in the case group. The TT + CT … that patients taking perhexiline or amiodarone should have …

… to avoid concomitant therapy with other drugs associated … of nadolol with low-dose
amiodarone is well tolerated and … placebo-controlled trial, perhexiline has shown the capacity to …

… peripheral neuropathy when given concomitantly with cisplatin without interfering with …
perhexiline, like amiodarone, is a lipophilic drug capable of penetrating lysozymes. Perhexiline …

… is concomitant with low hepatic energy production, the drugs … the antiarrhythmic drugs
amiodarone and perhexiline; drugs that … Moreover, in this case report a decrease in triglyceride …

… Exposure to class III antiarrhythmic drugs was 4.0% in cases and 1.5% in controls, aOR =
3.6 (95% CI: 1.6–8.4). Associations with exposure to dronedarone and amiodarone were …